The basis of Parkinson disease (PD) pathology is accumulation of α-synuclein particles (Lewy bodies) in the presynaptic terminal and perikaria of neocortex, cerebellum, thalamus and SN.
Features of the lipid profile specially cholesterol levels are association with PD risk. However no such data exists on the association of these plasma markers with structural brain changes in PD. The primary site of PD pathology is the nigrostriatal tract which then progresses to the cingulium. The nigrostriatal tract is extensively damaged prior to PD onset. Lower plasma levels of apoA-I is associated with earlier onset of PD and greater putaminal DAT deficit and a more rapid motor decline in PD . However apoA-I levels have never been investigated regarding changes in structural brain connectivity. The our results show that apoA-I levels in drug_naïve patients are associated with structural changes in the even prior to pathologic involvement of cingulium.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords